|
1
|
Rao KM: Molecular mechanisms regulating
iNOS expression in various cell types. J Toxicol Environ Health B
Crit Rev. 3:27–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aktan F: iNOS-mediated nitric oxide
production and its regulation. Life Sci. 75:639–653. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Green SJ, Mellouk S, Hoffman SL, Meltzer
MS and Nacy CA: Cellular mechanisms of nonspecific immunity to
intracellular infection: cytokine-induced synthesis of toxic
nitrogen oxides from L-arginine by macrophages and hepatocytes.
Immunol Lett. 25:15–19. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li LM, Kilbourn RG, Adams J and Fidler IJ:
Role of nitric oxide in lysis of tumor cells by cytokine-activated
endothelial cells. Cancer Res. 51:2531–2535. 1991.PubMed/NCBI
|
|
5
|
Langrehr JM, Hoffman RA, Billiar TR, Lee
KK, Schraut WH and Simmons RL: Nitric oxide synthesis in the in
vivo allograft response: a possible regulatory mechanism. Surgery.
110:335–342. 1991.PubMed/NCBI
|
|
6
|
Brown GC and Neher JJ: Inflammatory
neurodegeneration and mechanisms of microglial killing of neurons.
Mol Neurobiol. 41:242–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Annane D, Sanquer S, Sébille V, Faye A,
Djuranovic D, Raphaël JC, Gajdos P and Bellissant E:
Compartmentalised inducible nitric-oxide synthase activity in
septic shock. Lancet. 355:1143–1148. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu J, Yamane H and Paul WE:
Differentiation of effector CD4 T cell populations (*). Annu Rev
Immunol. 28:445–489. 2010. View Article : Google Scholar
|
|
9
|
Goldring CE, Reveneau S, Algarté M and
Jeannin JF: In vivo footprinting of the mouse inducible nitric
oxide synthase gene: inducible protein occupation of numerous sites
including Oct and NF-IL6. Nucleic Acids Res. 24:1682–1687. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burke SJ, Updegraff BL, Bellich RM, Goff
MR, Lu D, Minkin SC Jr, Karlstad MD and Collier JJ: Regulation of
iNOS gene transcription by IL-1β and IFN-γ requires a coactivator
exchange mechanism. Mol Endocrinol. 27:1724–1742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu C, Wu L and Li X: IL-17 family:
cytokines, receptors and signaling. Cytokine. 64:477–485. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Komiyama Y, Nakae S, Matsuki T, Nambu A,
Ishigame H, Kakuta S, Sudo K and Iwakura Y: IL-17 plays an
important role in the development of experimental autoimmune
encephalomyelitis. J Immunol. 177:566–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith E, Prasad KM, Butcher M, Dobrian A,
Kolls JK, Ley K and Galkina E: Blockade of interleukin-17A results
in reduced atherosclerosis in apolipoprotein E-deficient mice.
Circulation. 121:1746–1755. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laan M, Lötvall J, Chung KF and Lindén A:
IL-17-induced cytokine release in human bronchial epithelial cells
in vitro: role of mitogen-activated protein (MAP) kinases. Br J
Pharmacol. 133:200–206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Do H, Pyo S and Sohn EH: Suppression of
iNOS expression by fucoidan is mediated by regulation of p38 MAPK,
JAK/STAT, AP-1 and IRF-1, and depends on upregulation of scavenger
receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6
glioma cells. J Nutr Biochem. 21:671–679. 2010. View Article : Google Scholar
|
|
16
|
Ouyang W, Kolls JK and Zheng Y: The
biological functions of T helper 17 cell effector cytokines in
inflammation. Immunity. 28:454–467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Griffin GK, Newton G, Tarrio ML, Bu DX,
Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW,
Croce KJ and Lichtman AH: IL-17 and TNF-α sustain neutrophil
recruitment during inflammation through synergistic effects on
endothelial activation. J Immunol. 188:6287–6299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito
K, Kanayama M, Kurotaki D, Morimoto J, Iwakura Y, Yagita H, et al:
Interleukin-17A deficiency accelerates unstable atherosclerotic
plaque formation in apolipoprotein E-deficient mice. Arterioscler
Thromb Vasc Biol. 32:273–280. 2012. View Article : Google Scholar
|
|
19
|
Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran
H, Gallo A, Sokol SI, Pfau S, Pober JS and Tellides G:
Interleukin-17 and interferon-gamma are produced concomitantly by
human coronary artery-infiltrating T cells and act synergistically
on vascular smooth muscle cells. Circulation. 119:1424–1432. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pautz A, Art J, Hahn S, Nowag S, Voss C
and Kleinert H: Regulation of the expression of inducible nitric
oxide synthase. Nitric Oxide. 23:75–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trinh B, Ko SY, Haria D, Barengo N and
Naora H: The homeo-protein DLX4 controls inducible nitric oxide
synthase-mediated angiogenesis in ovarian cancer. Mol Cancer.
14:972015. View Article : Google Scholar
|
|
22
|
Ruddy MJ, Wong GC, Liu XK, Yamamoto H,
Kasayama S, Kirkwood KL and Gaffen SL: Functional cooperation
between interleukin-17 and tumor necrosis factor-alpha is mediated
by CCAAT/enhancer-binding protein family members. J Biol Chem.
279:2559–2567. 2004. View Article : Google Scholar
|
|
23
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jaramillo M, Naccache PH and Olivier M:
Monosodium urate crystals synergize with IFN-gamma to generate
macrophage nitric oxide: involvement of extracellular
signal-regulated kinase 1/2 and NF-kappa B. J Immunol.
172:5734–5742. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abramson SB, Amin AR, Clancy RM and Attur
M: The role of nitric oxide in tissue destruction. Best Pract Res
Clin Rheumatol. 15:831–845. 2001. View Article : Google Scholar
|
|
26
|
Hu X and Ivashkiv LB: Cross-regulation of
signaling pathways by interferon-gamma: implications for immune
responses and autoimmune diseases. Immunity. 31:539–550. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Boxel-Dezaire AH and Stark GR: Cell
type-specific signaling in response to interferon-gamma. Curr Top
Microbiol Immunol. 316:119–154. 2007.PubMed/NCBI
|
|
28
|
Varinou L, Ramsauer K, Karaghiosoff M,
Kolbe T, Pfeffer K, Müller M and Decker T: Phosphorylation of the
Stat1 transactivation domain is required for full-fledged
IFN-gamma-dependent innate immunity. Immunity. 19:793–802. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takauji R, Iho S, Takatsuka H, Yamamoto S,
Takahashi T, Kitagawa H, Iwasaki H, Iida R, Yokochi T and Matsuki
T: CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent
STAT1 phosphorylation in human plasma-cytoid dendritic cell
precursors. J Leukoc Biol. 72:1011–1019. 2002.PubMed/NCBI
|
|
30
|
Beurel E and Jope RS: Glycogen synthase
kinase-3 promotes the synergistic action of interferon-gamma on
lipopolysaccharide-induced IL-6 production in RAW264.7 cells. Cell
Signal. 21:978–985. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Raschke WC, Baird S, Ralph P and Nakoinz
I: Functional macrophage cell lines transformed by Abelson leukemia
virus. Cell. 15:261–267. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ralph P and Nakoinz I: Phagocytosis and
cytolysis by a macrophage tumour and its cloned cell line. Nature.
257:393–394. 1975. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ralph P, Prichard J and Cohn M: Reticulum
cell sarcoma: an effector cell in antibody-dependent cell-mediated
immunity. J Immunol. 114:898–905. 1975.PubMed/NCBI
|
|
34
|
Potter M and Lieberman R: Common
individual antigenic determinants in five of eight BALB-c IgA
myeloma proteins that bind phosphoryl choline. J Exp Med.
132:737–751. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sharshar T, Gray F, Lorin de la
Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D,
Raphael JC, Gajdos P and Annane D: Apoptosis of neurons in
cardiovascular autonomic centres triggered by inducible nitric
oxide synthase after death from septic shock. Lancet.
362:1799–1805. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hall JP and Davis RJ: Inhibition of the
p38 pathway upregulates macrophage JNK and ERK activities, and the
ERK, JNK, and p38 MAP kinase pathways are reprogrammed during
differentiation of the murine myeloid M1 cell line. J Cell Biochem.
86:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leonardi C, Matheson R, Zachariae C,
Cameron G, Li L, Edson-Heredia E, Braun D and Banerjee S:
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic
plaque psoriasis. N Engl J Med. 366:1190–1199. 2012. View Article : Google Scholar : PubMed/NCBI
|
